Brain scans reveal drugs' effects on attention
(Medical Xpress) -- Scientists have developed a way to evaluate new treatments for some forms of attention deficit disorder.
Oct 14, 2011
0
0
(Medical Xpress) -- Scientists have developed a way to evaluate new treatments for some forms of attention deficit disorder.
Oct 14, 2011
0
0
In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib ...
Dec 28, 2016
0
34
Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings ...
Sep 12, 2011
0
0
Researchers at Children's National Medical Center have found that a cholesterol-lowering statin drug appears to be safe in children with neurofibromatosis type 1 (NF1) and may improve learning disabilities, including verbal ...
Sep 27, 2011
0
1
International collaborative research led by Ludwine Messiaen, Ph.D., shows that while a three-base pair, in-frame deletion called p.Met992del in the NF1 gene has a mild phenotype for people with the genetic disorder neurofibromatosis ...
Sep 18, 2018
0
9
The research group of the neurofibromatosis of the Catalan Institute of Oncology (ICO), the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Institute of Medicicina Predictive and Personalized Cancer (IMPPC) ...
Apr 16, 2015
0
16
Physician-researchers at Indiana University School of Medicine have reported the first effective therapy for a class of previously untreatable and potentially life-threatening tumors often found in children.
Nov 1, 2012
0
0
University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...
May 20, 2013
0
0